Bexion Pharmaceuticals is a pioneering company in the biotechnology and pharmaceuticals sector, focusing on innovative therapies for oncology and central nervous system disorders. With its lead product BXQ-350, the company aims to deliver transformative solutions through novel S1P reduction properties and targeted approaches.
Specialties
Oncology-focused therapies
Central nervous system treatments
Innovative S1P reduction
Targeted therapeutic approaches
Biotechnology advancements
Products & Services
Oncology Therapies
CNS Disorder Treatments
Biotechnological Innovations
Pharmaceutical Research
S1P Reduction Compounds
Contact Information
No contact information available
Competitors & Similar Companies(9)
Amgen
California, • United States
Biogen
Massachusetts, • United States
Genentech
California, • United States
Vertex Pharmaceuticals
Massachusetts, • United States
AstraZeneca
Greater London, • United Kingdom
Regeneron Pharmaceuticals
New York, • United States
Celgene (Bristol-Myers Squibb)
New York, • United States
Novartis
Basel-City, • Switzerland
Incyte Corporation
Delaware, • United States
News & Media
Search Terms:
bexion pharmaceuticals
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Bexion Pharmaceuticals
Where is Bexion Pharmaceuticals located?
The headquarter of Bexion Pharmaceuticals is located in Covington, Kentucky, United States
What is the official website of Bexion Pharmaceuticals?
Who are the competitors of Bexion Pharmaceuticals?
Competitors of Bexion Pharmaceuticals are Amgen, Biogen, Genentech, Vertex Pharmaceuticals, AstraZeneca, Regeneron Pharmaceuticals, Celgene (Bristol-Myers Squibb), Novartis, Incyte Corporation.
What does Bexion Pharmaceuticals do?
Bexion Pharmaceuticals is a pioneering company in the biotechnology and pharmaceuticals sector, focusing on innovative therapies for oncology and central nervous system disorders. With its lead product BXQ-350, the company aims to deliver transformative solutions through novel S1P reduction properties and targeted approaches.
What are the social media links of Bexion Pharmaceuticals?